Plasma prolactin and growth hormone levels in manic patients treated with pimozide.
During two weeks' treatment of 11 manic patients with pimozide there was close correspondence between the timecourse of improvement in clinical ratings and the rise in plasma prolactin between the second and fourteenth day. There were no significant differences in growth hormone levels during the manic episodes compared to recovery. These findings are discussed in relation to the role of dopamine in the release of prolactin and growth hormone, and in the pathogenesis of mania.
D000328:Adult; D000341:Affective Disorders, Psychotic / Q000188:drug therapy*; D000368:Aged; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010868:Pimozide / Q000097:blood / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood*
D010868:Pimozide; D011388:Prolactin; D013006:Growth Hormone